Back to LLY
Aberdeen Group plc LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
18
Latest value
$176.9M
Q3 2026
Peak value
$582.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $145.6M |
| Q3 2025 | $349.3M |
| Q3 2025 | $123.4M |
| Q4 2025 | $503.5M |
| Q4 2025 | $118M |
| Q4 2025 | $181.6M |
| Q1 2026 | $150.5M |
| Q1 2026 | $450.9M |
| Q1 2026 | $64.8M |
| Q2 2026 | $582.3M |
| Q2 2026 | $182.7M |
| Q2 2026 | $54M |
| Q3 2026 | $69.6M |
| Q3 2026 | $558.4M |
| Q3 2026 | $176.9M |
| Q3 2026 | $558.4M |
| Q3 2026 | $69.6M |
| Q3 2026 | $176.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $176.9M | 152.9K | — | — |
| Q3 2026 | $69.6M | 60.2K | — | — |
| Q3 2026 | $558.4M | 482.6K | — | — |
| Q3 2026 | $176.9M | 152.9K | — | — |
| Q3 2026 | $558.4M | 482.6K | — | — |
| Q3 2026 | $69.6M | 60.2K | — | — |
| Q2 2026 | $54M | 45.0K | — | — |
| Q2 2026 | $182.7M | 152.3K | — | — |
| Q2 2026 | $582.3M | 485.5K | — | — |
| Q1 2026 | $64.8M | 70.5K | — | — |
| Q1 2026 | $450.9M | 490.2K | — | — |
| Q1 2026 | $150.5M | 163.7K | — | — |
| Q4 2025 | $181.6M | 169.0K | — | — |
| Q4 2025 | $118M | 109.8K | — | — |
| Q4 2025 | $503.5M | 468.5K | — | — |
| Q3 2025 | $123.4M | 168.7K | — | — |
| Q3 2025 | $349.3M | 477.3K | — | — |
| Q3 2025 | $145.6M | 199.0K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B